The Newsroom of Braasch Biotech LLC

Braasch Press Releases

  • Published on February 26, 2021 - 06:00 GMT

    Brazilian Patent Allowance for Obesity Pet Vaccines to Braasch Biotech LLC.

    Novel vaccines for therapeutic treatment of obesity in pets (dogs, cats, horses) GARRETSON, SD, US, February 26, 2021 /⁨EINPresswire.com⁩/ -- Braasch Biotech LLC, an emerging biopharmaceutical company pioneering a new field of anti-somatostatin vaccines, today announced a Notice of Allowance was received from the Brazilian Intellectual Property Office for Braasch’s patent entitled “Compositions and Methods for Enhanced Somatostatin Immunogenicity in the Treatment of Growth Hormone Deficiency.” The …

  • Published on February 24, 2021 - 19:48 GMT

    Brazil Patent Allowance for Human Obesity Vaccines to Braasch Biotech

    New Patent for Therapeutic Vaccine Treatment for Obesity in humans. GARRETSON, SD, US, February 24, 2021 /⁨EINPresswire.com⁩/ -- Braasch Biotech LLC, an emerging biopharmaceutical company pioneering a new field of anti-somatostatin vaccines, today announced a Notice of Allowance was received from the Brazilian Intellectual Property Office for Braasch’s patent entitled “Compositions and Methods for Enhanced Somatostatin Immunogenicity in the Treatment of Growth Hormone Deficiency.” The Patent Allowance …

    Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...